Activating mutation of Ras is associated with CDCP1 expression in NSCLC. A, NSCLC cell lines with Ras + B-Raf mutations and wild-type Ras were examined.

Slides:



Advertisements
Similar presentations
The expression and signaling of FGFR3 in WM cells.
Advertisements

AZD9291 inhibits EGFR phosphorylation and downstream signaling in murine models of EGFRT790M-resistant lung cancer. AZD9291 inhibits EGFR phosphorylation.
PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation. PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation.
Oncogenic B-Raf mutations
IHC staining of FFPE esophageal tissues in tissue microarrays (×20).
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
Deficiency of Cdkn2a leads to aberrant activation of RhoA in vivo.
Microarray analysis of phospho-Twist1–responsive genes.
Quantitative PCR of CRTAC1 (white columns) and WASF1 (black columns) loci in germ line DNA (A), glomus tumor no. 1 (B), and glomus tumor no. 3 (C) from.
Fig. 5 EGFR mutation status of patients with NSCLC, detected by histological examination and ARMS PCR. EGFR mutation status of patients with NSCLC, detected.
Collagen-dependent phosphorylation of eIF4E in PDAC cells.
Expression of σ in SCCs Expression of σ in SCCs. Shown is a magnified section of a representative 2D PAGE gel run with a lysate from an SCC.
NICD1 immunohistochemical staining in normal and tumor tissue.
SIRT1 is downregulated in human gastric cancer (GC).
BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR signaling in the NNK-treated mice. BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR.
Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.
TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.
Cytotoxic activity of HER2-lytic hybrid peptide.
Immunohistochemical analyses of SHH expression levels in nonmalignant prostate and adenocarcinoma tissues. Immunohistochemical analyses of SHH expression.
The expression of SPINDLIN1 in cancer tissues.
Oncogenic Ras signaling activates SFKs and promotes CDCP1-dependent invasion in 3-dimensional (3D) collagen raft culture of HCK. A, HCK1T-E cells, HCK1T-E.
Gramicidin A (GA) decreases HIF protein expression in RCC cells.
FOXO3a phosphorylation and expression.
CDCP1 is required for invadopodia formation and ECM degradation by human breast cancer cells. CDCP1 is required for invadopodia formation and ECM degradation.
BORIS mRNA expression in DNMT deficient HCT116 cell lines.
Induction of CDCP1 is regulated by Ras in NSCLC cells.
Geographic colocalization of PD-L1+ tumor cells with infiltrating immune cells in MCC. The predominant pattern of tumor cell PD-L1 expression is at the.
CDCP1 colocalizes and interacts with MT1-MMP.
Representative examples of estrogen receptor α and β immunohistochemical expression (top figures) and EGFR mutations (bottom figures) in lung adenocarcinomas.
Progastrin expression in colonic tissues and Kaplan–Meier survival curves. Progastrin expression in colonic tissues and Kaplan–Meier survival curves. A,
IL6 mRNA is not detected in metastatic prostate cancer cells.
Imatinib mesylate inhibits PDGF-mediated ERK and Akt activation.
MAPJD expression in lung cancers.
AXL is not expressed in human prostate tumors.
In vivo thrombosis of tumor vasculature.
Ki-67 expression is dynamically controlled by a cell-cycle–regulatory network. Ki-67 expression is dynamically controlled by a cell-cycle–regulatory network.
Greater induction of apoptosis following EGFR TKI treatment correlates with higher basal BIM expression across a panel of EGFR-mutant lung cancers. Greater.
Active AR signaling in enzalutamide-resistant xenograft tumors.
Excerpts of identified gene expression profiles.
SAF-1 expression in clinical breast cancer tissues.
IGF-IR in human head and neck cancer.
Targeting DCLK1 by miRNA-137.
Immunohistochemical analysis of dUTPase in human breast adenocarcinoma
Expression of XCR1 in normal ovarian surface epithelium and the IOSE and borderline EOC cell lines. Expression of XCR1 in normal ovarian surface epithelium.
CDCP1 links Ras and SFK signaling and regulates anoikis resistance, cell migration, and invasion in NSCLC cells. CDCP1 links Ras and SFK signaling and.
Ki-67 expression in M31- and H3-treated tumors (A) and respective Ki-67 labeling indices in the two groups of tumors (B). Ki-67 expression in M31- and.
Interaction of Cdx1 and Cdx2 with the putative Cdx-binding sites of the human DSC2 promoter. Interaction of Cdx1 and Cdx2 with the putative Cdx-binding.
Platinum-based chemotherapy increased TXNIP expression, and overexpression of TXNIP enhanced the effectiveness of this therapy. Platinum-based chemotherapy.
Representative photograph of somatic mutations detected by PCR-SSCP.
Reduced klotho expression in pancreatic cancer.
In vivo demonstration of EMT in GFP-tagged tumors.
Tivantinib does not inhibit MET function.
Prevalence of germline T790M.
A and B, two blocks from the original specimen used for TMA demonstrated areas with varying patterns of ALK rearrangement and KRAS mutation status. A and.
Progastrin staining in colon adenomas and adenocarcinomas.
Histology (H&E; original magnification, ×100 for B-2P/C-12P/C-64P and ×40 for C-10P; top) of small-sized lung adenocarcinomas and immunohistochemical staining.
Reduced expression of the tumor suppressor PTEN occurs in tumors with both squamous cell and adenocarcinoma histology. Reduced expression of the tumor.
Validation of NAA's cancer specificity in lung cancer.
P53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo CreER angiosarcoma. p53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo.
Establishment of HeLa/rtTAA/TRE-N1-IC cell line.
Depleting NQO1 expression levels inhibits growth of NSCLC cells in soft agar. Depleting NQO1 expression levels inhibits growth of NSCLC cells in soft agar.
AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. A,
Immunohistochemical determination of TIM-3 expression in ccRCC.
CD36 expression in tissue adjacent and distal to the tumor.
Loss of NQO1 expression inhibits invasion of NSCLC
Comparison of PD-L1 mAbs in IHC across multiple tumor types.
Proteome changes associated with CHCHD2 expression in NSCLC cells.
CREB1 binds at the proximal region of the TGFB2 promoter and induces its transcriptional activation. CREB1 binds at the proximal region of the TGFB2 promoter.
Determination of Per2 (left), MTNR1A (middle), and ERβ (right) protein expression levels in mammary tissues of rats sacrificed at ZT12. Determination of.
IHC staining of FFPE esophageal tissues in tissue microarrays (×20).
Presentation transcript:

Activating mutation of Ras is associated with CDCP1 expression in NSCLC. A, NSCLC cell lines with Ras + B-Raf mutations and wild-type Ras were examined by qRT-PCR and compared with normal lung. Activating mutation of Ras is associated with CDCP1 expression in NSCLC. A, NSCLC cell lines with Ras + B-Raf mutations and wild-type Ras were examined by qRT-PCR and compared with normal lung. B, expression of CDCP1, ERK1/2, and phosphorylation of ERK1/2 in each cell line. Black arrowheads denote band corresponding to CDCP1. White arrowhead indicates nonspecific bands. C, the expression of CDCP1 and the ratio of phosphorylated ERK in each cell line. D, human lung cancer tissues with mutations of Ras and wild-type Ras were stained by CDCP1 antibody. Magnification, ×200. E, CDCP1 expression in human lung cancer tissues with mutations of Ras compared with wild-type Ras. P values in a Student t test = 0.009. Takamasa Uekita et al. Mol Cancer Res 2014;12:1449-1459 ©2014 by American Association for Cancer Research